MedTrace Logo

Short Term Corticosteroids in SARS-CoV2 Patients

NCT04445506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-06-24

No results posted yet for this study

Summary

The investigators reviewed the charts of SARS-CoV-2 patients with pneumonia and moderate to severely elevated CRP and worsening hypoxemia who were treated with early, short-term dexamethasone.

Conditions

Interventions

DRUG

Dexamethasone

4mg dexamethasone was given to some patients three times daily for 2 days, 2 times daily for 2 days, once daily for 2 days.

Sponsors & Collaborators

  • The Miriam Hospital

    lead OTHER

Principal Investigators

  • Kwame Dapaah-Afriyie, MD · The Miriam Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-05-31
Completion
2020-05-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04445506 on ClinicalTrials.gov